Theravance Biopharma (TBPH) Selling, General & Administrative (2013 - 2026)
Theravance Biopharma (TBPH) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
-7.36 Mn |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
17.72 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
17.72 Mn |
| Dec 31, 2025 |
18.52 Mn |
| Sep 30, 2025 |
18.33 Mn |
| Jun 30, 2025 |
18.43 Mn |
| Mar 31, 2025 |
18.37 Mn |
| Dec 31, 2024 |
18.50 Mn |
| Sep 30, 2024 |
16.88 Mn |
| Jun 30, 2024 |
17.06 Mn |
| Mar 31, 2024 |
16.74 Mn |
| Dec 31, 2023 |
15.49 Mn |
| Sep 30, 2023 |
16.14 Mn |
| Jun 30, 2023 |
19.28 Mn |
| Mar 31, 2023 |
19.18 Mn |
| Dec 31, 2022 |
16.73 Mn |
| Sep 30, 2022 |
16.28 Mn |
| Jun 30, 2022 |
16.22 Mn |
| Mar 31, 2022 |
17.84 Mn |
| Dec 31, 2021 |
21.52 Mn |
| Sep 30, 2021 |
21.30 Mn |
| Jun 30, 2021 |
25.93 Mn |
